These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 8627185)
1. Two levels of help for B cell alloantibody production. Steele DJ; Laufer TM; Smiley ST; Ando Y; Grusby MJ; Glimcher LH; Auchincloss H J Exp Med; 1996 Feb; 183(2):699-703. PubMed ID: 8627185 [TBL] [Abstract][Full Text] [Related]
2. IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection. Effects of transplantectomy and posttransplantation blood transfusion. Wray DW; Baldwin WM; Sanfilippo F Transplantation; 1992 Jan; 53(1):167-74. PubMed ID: 1370736 [TBL] [Abstract][Full Text] [Related]
3. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. Lee RS; Grusby MJ; Glimcher LH; Winn HJ; Auchincloss H J Exp Med; 1994 Mar; 179(3):865-72. PubMed ID: 8113680 [TBL] [Abstract][Full Text] [Related]
4. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Auchincloss H; Lee R; Shea S; Markowitz JS; Grusby MJ; Glimcher LH Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3373-7. PubMed ID: 8475083 [TBL] [Abstract][Full Text] [Related]
5. CD4 T cells can reject major histocompatibility complex class I-incompatible skin grafts. Wise M; Zelenika D; Bemelman F; Latinne D; Bazin H; Cobbold S; Waldmann H Eur J Immunol; 1999 Jan; 29(1):156-67. PubMed ID: 9933097 [TBL] [Abstract][Full Text] [Related]
6. CD8+ effector cells responding to residual class I antigens, with help from CD4+ cells stimulated indirectly, cause rejection of "major histocompatibility complex-deficient" skin grafts. Lee RS; Grusby MJ; Laufer TM; Colvin R; Glimcher LH; Auchincloss H Transplantation; 1997 Apr; 63(8):1123-33. PubMed ID: 9133474 [TBL] [Abstract][Full Text] [Related]
7. Indirect allorecognition of platelets by T helper cells during platelet transfusions correlates with anti-major histocompatibility complex antibody and cytotoxic T lymphocyte formation. Semple JW; Speck ER; Milev YP; Blanchette V; Freedman J Blood; 1995 Jul; 86(2):805-12. PubMed ID: 7606011 [TBL] [Abstract][Full Text] [Related]
8. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity. Taylor AL; Negus SL; Negus M; Bolton EM; Bradley JA; Pettigrew GJ Transplantation; 2007 Apr; 83(7):931-7. PubMed ID: 17460565 [TBL] [Abstract][Full Text] [Related]
9. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection. Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ Front Immunol; 2018; 9():3039. PubMed ID: 30740108 [TBL] [Abstract][Full Text] [Related]
10. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. Pietra BA; Wiseman A; Bolwerk A; Rizeq M; Gill RG J Clin Invest; 2000 Oct; 106(8):1003-10. PubMed ID: 11032860 [TBL] [Abstract][Full Text] [Related]
11. A novel tool for B-cell tolerance research: characterization of mouse alloantibody development using a simple and reliable cellular ELISA technique. Fan X; Tyerman K; Ang A; Koo K; Parameswaran K; Tao K; Mai L; Lang H; West LJ Transplant Proc; 2005; 37(1):29-31. PubMed ID: 15808536 [TBL] [Abstract][Full Text] [Related]
12. The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice. Vallera DA; Taylor PA; Sprent J; Blazar BR Transplantation; 1994 Jan; 57(2):249-56. PubMed ID: 7906058 [TBL] [Abstract][Full Text] [Related]
13. Reduction of alloantibody response to class I major histocompatibility complex by targeting synthetic allopeptides for presentation by B cells. MacDonald CM; Bolton EM; Jaques BC; Walker KG; Bradley JA Transplantation; 1997 Apr; 63(7):926-32. PubMed ID: 9112341 [TBL] [Abstract][Full Text] [Related]
14. Dissociation of mouse cardiac transplant rejection and donor alloantigen-specific T cell responsiveness. Bishop DK; DeBruyne LA; Chan S; Xu S; Eichwald EJ Transpl Immunol; 1995 Sep; 3(3):222-8. PubMed ID: 8581410 [TBL] [Abstract][Full Text] [Related]
15. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens. Tomita Y; Mayumi H; Eto M; Nomoto K J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930 [TBL] [Abstract][Full Text] [Related]
16. Anti-donor MHC Class II Alloantibody Induces Glomerular Injury in Mouse Renal Allografts Subjected to Prolonged Cold Ischemia. Gorbacheva V; Fan R; Beavers A; Fairchild RL; Baldwin WM; Valujskikh A J Am Soc Nephrol; 2019 Dec; 30(12):2413-2425. PubMed ID: 31597715 [TBL] [Abstract][Full Text] [Related]
17. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts. Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590 [TBL] [Abstract][Full Text] [Related]
18. Class II major histocompatibility complex-restricted T cell function in CD4-deficient mice. Rahemtulla A; Kündig TM; Narendran A; Bachmann MF; Julius M; Paige CJ; Ohashi PS; Zinkernagel RM; Mak TW Eur J Immunol; 1994 Sep; 24(9):2213-8. PubMed ID: 7916297 [TBL] [Abstract][Full Text] [Related]
19. Fluorescent target array T helper assay: a multiplex flow cytometry assay to measure antigen-specific CD4+ T cell-mediated B cell help in vivo. Quah BJ; Wijesundara DK; Ranasinghe C; Parish CR J Immunol Methods; 2013 Jan; 387(1-2):181-90. PubMed ID: 23123200 [TBL] [Abstract][Full Text] [Related]
20. IL-2 and a contact-mediated signal provided by TCR alpha beta + or TCR gamma delta + CD4+ T cells induce polyclonal Ig production by committed human B cells. Enhancement by IL-5, specific inhibition of IgA synthesis by IL-4. van Vlasselaer P; Gascan H; de Waal Malefyt R; de Vries JE J Immunol; 1992 Mar; 148(6):1674-84. PubMed ID: 1347306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]